Are pilocarpine drops safe for presbyopia?

Low-dose pilocarpine is well tolerated in most patients. The most common side effects are brow ache, mild headache and dim low-light vision because of the smaller pupil. A very small increase in retinal detachment risk has been reported, particularly in highly myopic eyes; a peripheral retinal review before starting drops is standard practice.

Is the drops route cheaper than presbyopia surgery overall?

For 1 to 2 years, drops are cheaper. Beyond 5 years they usually are not: drops typically cost GBP 1,500 to 3,500 at the five-year mark and continue indefinitely; surgery is GBP 5,000 to 10,500 once. Over a 10 to 15 year horizon, surgery is usually significantly cheaper than continuous daily drops, and gives all-day spectacle independence.

Which presbyopia surgery gives the best near vision?

For pure near reading vision, trifocal intraocular lenses (PanOptix Pro, AT LISA tri, FineVision) give the largest near gain. Extended depth of focus (EDOF) lenses (Vivity, Symfony), the IC-8 Apthera small-aperture IOL and PRESBYOND laser blended vision give very good intermediate-to-near vision with cleaner night vision and less dysphotopsia. The right choice depends on visual priorities, occupation and any pre-existing eye conditions.

How urgent is the decision between drops and surgery?

Presbyopia is a natural age-related change, not a sight-threatening condition, so there is no medical urgency. The right time to treat is when reading, screens and dashboard vision interfere with daily life enough that a solution matters. A free consultation will set out the options on your own timescale.

Prices · Presbyopia · Vuity Drops vs Surgery · Updated May 2026

Private Vuity presbyopia drops vs surgery: UK 2026 cost comparison

Q: Can I buy Vuity in the UK in 2026?

Vuity, the US AbbVie/Allergan brand of low-dose pilocarpine 1.25 percent ophthalmic solution, is not currently MHRA-licensed in the UK in 2026. UK private ophthalmologists can prescribe pilocarpine 1.25 percent off-licence as a special order through a specialist pharmacy, and similar low-dose pilocarpine formulations are available through specialist providers. The clinical effect is the same.

Q: How quickly do the drops work and how long do they last?

The near-vision effect of low-dose pilocarpine typically comes on around 15 to 20 minutes after instillation and lasts 4 to 6 hours, after which the pupil re-dilates and near vision returns to baseline. Re-dosing is required for continued effect.

Q: Will the drops replace my reading glasses completely?

For most adults, the drops give a useful boost: around 30 to 40 percent of treated emmetropic presbyopes gained three or more lines of near acuity in the GEMINI 1 and GEMINI 2 trials. Most people still keep a pair of light reading glasses on hand for prolonged or very small print.

Q: Can I drive at night while using the drops?

The pupil constriction makes low-light vision slightly dimmer, and some patients prefer not to take the drops on days they are doing significant night driving. Many users dose earlier in the day so the effect has worn off by dusk and night vision returns to normal.

Q: What if I am only 45 and do not yet have a cataract?

PRESBYOND laser blended vision (Zeiss) is usually the best fit at age 45 with a healthy cornea and no cataract; it preserves your natural lens and gives reliable spectacle independence for many years. Pilocarpine 1.25 percent drops are a reasonable interim measure if you are not ready to commit to surgery.

Q: What if I am 60 and have an early cataract?

At 60 with an early cataract, refractive lens exchange or cataract surgery with a premium intraocular lens (trifocal, EDOF, Light Adjustable Lens or IC-8 Apthera) addresses both presbyopia and cataract in one step and removes the future need for separate cataract surgery later.

Vuity (pilocarpine 1.25%) is a low-dose pilocarpine eye drop used in many countries to give a temporary boost to near vision in adults with presbyopia — the age-related loss of focusing power that usually starts around the mid-forties. In the UK in 2026, Vuity itself is not a Medicines and Healthcare products Regulatory Agency (MHRA)-licensed product, but pilocarpine 1.25% can be prescribed off-licence by a UK private ophthalmologist where appropriate, and similar low-dose pilocarpine formulations are available through specialist providers. This page compares the realistic cost of going down the drops route with the cost of the surgical options for presbyopia at CQC-registered UK clinics in 2026 — including refractive lens exchange, PRESBYOND blended vision, EDOF and trifocal intraocular lenses, light-adjustable lenses, and the IC-8 Apthera small-aperture IOL — so you can see how the numbers add up over five and ten years.

Vuity-equivalent drops: ongoing daily cost; typical 5-year spend approximately £1,500-£3,500.
PRESBYOND blended vision: roughly £5,000-£6,500 (both eyes), one-off cost.
Refractive lens exchange: £5,500-£9,500 (both eyes) with monofocal/EDOF/trifocal options.
Best for drops: early presbyopia, wanting a non-surgical try before committing.
Best for surgery: reliable spectacle reduction for the long term; cataract present.

Private consultant refractive surgery assessment: 0800 852 7782. Same-week appointments at CQC-registered UK clinics; transparent UK 2026 self-pay and insurer-billed pathways.

Fast answer: should you pay for Vuity drops or for surgery?

If you have early presbyopia, want occasional reading help and are not ready for surgery, low-dose pilocarpine drops can give a useful short-term near-vision boost — but they have a daily cost, dim the room slightly and only work for a few hours at a time. If you want reliable, long-term spectacle reduction, surgery (PRESBYOND laser, refractive lens exchange with an EDOF, trifocal or light-adjustable IOL, or the IC-8 Apthera small-aperture IOL) is a one-off investment that, over five to ten years, usually works out cheaper than continuous drops and gives you all-day vision without dim spots or dosing.

Pilocarpine 1.25% drops

~£30-£60 per month; 5-year spend ~£1,500-£3,500.

PRESBYOND blended vision

~£5,000-£6,500 both eyes, one-off.

Refractive lens exchange

~£5,500-£9,500 both eyes (lens choice dependent).

Trifocal/EDOF IOL upgrade

+£1,200-£2,800 per eye over monofocal.

Honest one-liner: drops are a useful try-before-you-buy in early presbyopia; surgery wins on cost-per-year, hours-per-day, and freedom-from-dosing as soon as you commit to a 5-10 year horizon.

What is Vuity and how does it work?

Vuity (AbbVie/Allergan) is a US brand of low-dose pilocarpine hydrochloride 1.25% ophthalmic solution. Pilocarpine is a parasympathomimetic agent that has been used in ophthalmology for decades, but in this much lower concentration it works principally by mildly constricting the pupil. A smaller pupil acts like the small aperture on a camera: it extends depth of focus, so that close-up objects come into clearer view without significantly compromising distance vision. The effect comes on in 15 to 20 minutes after instillation and typically lasts between four and six hours.

In the UK, Vuity itself does not currently hold an MHRA marketing authorisation in 2026. UK private ophthalmologists can, however, prescribe pilocarpine 1.25% off-licence as a special order through specialist pharmacies, and a number of similar low-dose pilocarpine formulations are emerging across Europe. The clinical effect is the same whether the bottle has the Vuity label or a UK pharmacist’s special label: pupil constriction, a small monocular gain in near vision, and a need to dose once or twice a day for ongoing effect.

UK 2026 cost comparison: drops vs surgery for presbyopia

Option	Initial / yearly UK 2026 cost	5-year total (typical)	Notes
Pilocarpine 1.25% drops (Vuity-equivalent)	£30-£60/month private prescription	£1,500-£3,500	Ongoing cost; consultant review and follow-up extra.
Reading glasses	£50-£400 per pair	£150-£800	Cheapest option; daily inconvenience; needs replacing.
PRESBYOND laser blended vision	£5,000-£6,500 both eyes, one-off	£5,000-£6,500	Best for 45-55 with healthy cornea and no cataract.
Refractive lens exchange (monofocal/EDOF)	£5,500-£8,000 both eyes, one-off	£5,500-£8,000	Removes future cataract; choice of lens technologies.
Trifocal IOL refractive lens exchange	£7,500-£9,500 both eyes, one-off	£7,500-£9,500	Best for spectacle independence at all distances.
Light Adjustable Lens (LAL)	£7,500-£10,500 both eyes, one-off	£7,500-£10,500	Post-op fine-tuning of refraction via UV light treatments.
IC-8 Apthera small-aperture IOL	£7,000-£9,500 both eyes, one-off	£7,000-£9,500	Good extended depth of focus; useful in eyes with mild aberrations.

Surgical figures are typical UK 2026 self-pay ranges at CQC-registered clinics. The 5-year total for drops assumes daily dosing in one or both eyes and excludes the cost of consultant reviews, optical surface treatments and any reading glasses still required. See our dedicated pages on refractive lens exchange cost, trifocal IOL cost, EDOF lens cost and Eyhance enhanced monofocal cost for breakdowns by lens.

What is included in each pathway?

Pilocarpine 1.25% drops

Consultant ophthalmology consultation, refraction, ocular health workup, private prescription, dispensing through a specialist pharmacy, structured 4-6 week follow-up to confirm tolerance and effect.

PRESBYOND laser blended vision

Consultant refractive consultation, full corneal imaging, treatment in both eyes, post-op drops and follow-up to 12 months, enhancement allowance where appropriate.

Refractive lens exchange

Biometry, lens-power calculation, day-case phacoemulsification with chosen IOL in both eyes, post-op drops and structured follow-up; YAG capsulotomy if needed later.

Light Adjustable Lens

All RLE inclusions plus a series of post-op light treatments to dial in the final refraction across the first weeks.

What does the evidence say?

For low-dose pilocarpine, the principal evidence base comes from the GEMINI 1 and GEMINI 2 Phase 3 trials that supported the US FDA approval of Vuity in 2021. In those studies, around 30 to 40% of treated emmetropic presbyopes gained three or more lines of near acuity at one hour post-dose without losing more than one line of distance acuity, with effect lasting up to six hours. Headache and conjunctival hyperaemia were the commonest side effects, and a small reduction in low-light contrast (the ‘dimmer room’ sensation) is intrinsic to the pupil-constricting mechanism.

For presbyopia surgery, the evidence base is mature and broad. PRESBYOND laser blended vision (Zeiss) consistently delivers binocular spectacle independence for many years in 45-55 year-olds with healthy corneas. EDOF lenses (Vivity, Symfony), enhanced monofocals (Tecnis Eyhance), trifocal lenses (PanOptix Pro, AT LISA tri, FineVision) and the IC-8 Apthera small-aperture IOL all have peer-reviewed prospective evidence for excellent distance and improved intermediate or near vision, with differing dysphotopsia trade-offs. The Light Adjustable Lens (RxSight) offers post-op refinement of the final refraction, which is particularly useful in eyes with prior corneal refractive surgery.

Critically, surgical interventions are one-off, do not produce a sustained ‘dim room’ effect, and continue to function for life. Drops, in contrast, must be used continually and only work for a few hours per dose — which is why the cost stacks up so differently when viewed over a 5-10 year horizon.

Drops vs surgery: side-by-side

Factor	Low-dose pilocarpine drops	Presbyopia surgery (PRESBYOND/RLE/IC-8/LAL)
Time to effect	15-20 minutes after each dose.	A few weeks of recovery, then stable for years.
Duration per use	4-6 hours; needs re-dosing.	All day, every day, for the working life of the eye.
Best near gain	~3 lines in around 30-40% of patients.	Functional near in the great majority; trifocal > EDOF > PRESBYOND > enhanced monofocal.
Side effects	Mild headache, dim low-light vision, hyperaemia.	Procedural risks; some dysphotopsia with multifocal lenses.
5-year cost	£1,500-£3,500 plus glasses still often needed.	£5,000-£10,500 one-off, depending on technology.
Cataract pathway	Still needed when cataract develops.	RLE/IOL options remove future cataract need.

See our pages on PRESBYOND laser blended vision, refractive lens exchange, light adjustable lens, PanOptix Pro trifocal IOL and IC-8 Apthera small-aperture IOL for procedure-by-procedure detail, or our presbyopia condition page for the underlying biology.

Who is each pathway right for?

Drops are a reasonable trial when

Aged 40-55 with early to moderate presbyopia.
Healthy eyes, no cataract or significant macular disease.
You want an occasional near boost rather than full spectacle independence.
You are not ready for laser or lens surgery yet.
You can tolerate mild low-light dimming and headache.

Consider surgery when

You want reliable, all-day spectacle independence.
You already have a cataract, however early.
You drive at night and want to avoid pupil-induced dim vision.
You expect to pay for drops for many years — surgery is cheaper over time.
You are happy with a single intervention rather than daily dosing.

A consultant refractive assessment with corneal imaging, biometry and an ocular surface review is the right first step. Book a free online consultation or make an in-person appointment to map your individual options.

NHS vs private: presbyopia care in the UK

Presbyopia is treated by the NHS as a refractive (lifestyle) condition rather than a sight-threatening disease, and is not generally funded for treatment outside of cataract surgery. NHS cataract surgery uses standard monofocal lenses set for distance; premium IOLs, refractive lens exchange in eyes without cataract, PRESBYOND laser, IC-8 Apthera and the Light Adjustable Lens are not available on the NHS. Likewise, pilocarpine 1.25% drops for presbyopia are typically a private prescription.

The private route gives access to the full menu, a comprehensive biometry and corneal workup, consultant-led care, and short waiting times. For most adults who actively want a permanent solution to reading vision, private surgery is the only realistic UK 2026 pathway.

Insurance and funding

UK private medical insurers typically do not fund refractive (lifestyle) treatments for presbyopia in eyes without cataract, including PRESBYOND laser, refractive lens exchange, and pilocarpine 1.25% drops. Where a cataract is present, cataract surgery itself is usually funded; any premium IOL upgrade (EDOF, trifocal, Light Adjustable Lens, IC-8 Apthera) is normally treated as a self-pay extra. See our insured patients page for a full overview.

For self-pay patients, transparent quotes and 0% finance options are common — see our finance page for arrangements that spread the cost. Comparing the 5- and 10-year total cost of drops against a one-off surgery often makes the financial decision straightforward.

Risks and limitations

Low-dose pilocarpine drops

Brow ache and headache: commonest side effect, especially in the first weeks.
Dim low-light vision: the smaller pupil reduces night driving comfort.
Hyperaemia and conjunctival redness: usually mild and self-limiting.
Retinal detachment risk: very rare; higher in highly myopic eyes with peripheral retinal weakness — warrants peripheral retinal review before starting.
Daily dosing: the effect wears off; the cost continues for life.

Presbyopia surgery

Dysphotopsia: mild glare and halos with multifocal/trifocal lenses; far less with PRESBYOND, EDOF, IC-8 and enhanced monofocals.
Refractive surprise: small risk addressed by accurate biometry; LAL allows post-op refinement.
YAG capsulotomy: a quick laser is needed in a proportion of patients later.
Infection (endophthalmitis): small (~1 in 1,000-2,000) risk shared with any intraocular surgery.
Cystoid macular oedema: small risk after any intraocular procedure; usually responds to drops.

Recovery and lifestyle impact

Pilocarpine drops

Drop in the eye(s) once or twice a day; near effect from 15-20 minutes for 4-6 hours; brow ache typically settles after 1-2 weeks.

PRESBYOND laser

Day-case bilateral surgery; comfortable from day 2; driving usually within a week; final visual settling over 1-3 months.

Refractive lens exchange

Sequential day-case surgery to each eye; office work in 1 week; driving once both eyes are stable and DVLA standard met.

Light Adjustable Lens

RLE recovery plus 2-4 light-treatment sessions starting 2-3 weeks after second eye to fine-tune the refraction.

How to choose a UK presbyopia clinic

Consultant refractive subspecialty: the surgeon should perform PRESBYOND/SMILE/LASIK as well as RLE with the full menu of IOLs.
Full presbyopia menu: the clinic should offer EDOF, trifocal, enhanced monofocal, Light Adjustable Lens and IC-8 Apthera, not just one platform.
Honest counselling: any clinic that pushes one option without discussing trade-offs is not a good fit.
Optometry-led aftercare: robust 12-month follow-up and enhancement provision in writing.
Pharmacy access: if you want a drops trial first, the clinic should arrange a regulated UK private prescription for pilocarpine 1.25% through a specialist pharmacy.
CQC registration and finance: day-case theatres should be CQC-registered with transparent fixed-fee finance options.

Book a free initial online consultation or read the broader post-cataract spectacle expectations article and the trifocal-vs-EDOF comparison for further reading.

Vuity drops vs surgery: frequently asked questions

Can I buy Vuity in the UK in 2026?

Vuity (the US AbbVie/Allergan brand of pilocarpine 1.25%) is not currently MHRA-licensed in the UK in 2026. UK private ophthalmologists can prescribe pilocarpine 1.25% off-licence as a special order, and similar low-dose pilocarpine formulations are available through specialist pharmacies. The clinical effect is the same.

How much does pilocarpine 1.25% cost in the UK per month?

Through a UK specialist pharmacy on private prescription, typical 2026 costs are around £30 to £60 per month per eye, depending on supplier and dosing. Over 5 years that is roughly £1,500 to £3,500 in drug costs alone.

How quickly do the drops work and how long do they last?

The near-vision effect generally comes on around 15-20 minutes after instillation and typically lasts 4-6 hours, after which the pupil re-dilates and near vision returns to baseline.

Will the drops replace my reading glasses completely?

For most adults the drops give a useful boost (around 30-40% gain three or more lines of near acuity) but most still keep a pair of light reading glasses on hand for prolonged or very small print.

Are pilocarpine drops safe?

Low-dose pilocarpine is well tolerated in most patients. The most common side effects are brow ache, mild headache and dim low-light vision. A very small increase in retinal detachment risk has been reported, particularly in highly myopic eyes; a peripheral retinal review before starting is standard practice.

Can I drive at night while using the drops?

The small pupil makes low-light vision slightly dimmer, and some patients prefer not to take the drops on days they are doing significant night driving. Many people use the drops earlier in the day so the effect has worn off by dusk.

Is the drops route cheaper than surgery overall?

For 1-2 years, yes. Beyond 5 years it usually is not: drops cost £1,500-£3,500 at 5 years and continue indefinitely; surgery is £5,000-£10,500 once. Over 10-15 years, surgery is usually significantly cheaper than ongoing drops.

Which surgery gives the best near vision?

For pure near reading vision, trifocal IOLs (PanOptix Pro, AT LISA tri, FineVision) give the largest near gain; EDOF lenses (Vivity, Symfony), the IC-8 Apthera and PRESBYOND blended vision give very good intermediate-to-near with cleaner night vision. Choice depends on your visual priorities and any pre-existing eye conditions.

What if I am only 45 and do not yet have a cataract?

PRESBYOND laser blended vision is usually the best fit; it preserves your natural lens and gives reliable spectacle independence for many years. Drops are a reasonable interim measure if you are not ready to commit.

What if I am 60 and have an early cataract?

Refractive lens exchange or cataract surgery with a premium IOL (trifocal, EDOF, Light Adjustable Lens or IC-8 Apthera) addresses both presbyopia and cataract in one step, and removes the future need for separate cataract surgery later.

Will my private medical insurance pay for the drops or surgery?

Usually no for either, because presbyopia is treated as a refractive (lifestyle) condition. If a cataract is present, cataract surgery is normally funded but the premium IOL upgrade is self-pay. Speak to your insurer with the consultant's letter and quote.

Can I try the drops first and then have surgery later?

Yes. Many patients use a few months of pilocarpine 1.25% as a try-before-you-buy to see how much near-vision gain matters to them in daily life, and then convert to PRESBYOND laser or refractive lens exchange once they are ready.

How urgent is the decision?

Presbyopia is not sight-threatening, so there is no medical urgency. The right time to treat is when reading and screen vision is interfering with daily life enough that you want a solution. A free consultation will lay out the options so you can decide on your timescale.

Methodology and sources

UK 2026 self-pay pricing on this page reflects published private fees from CQC-registered ophthalmic providers and specialist pharmacies at the time of last review (May 2026), expressed as typical ranges rather than fixed prices. Clinical content has been written by the Eye Surgery Clinic editorial team, reviewed by a UK GMC-registered consultant ophthalmologist with refractive subspecialty interest. Evidence for pilocarpine 1.25% draws on the AbbVie/Allergan GEMINI 1 and GEMINI 2 Phase 3 trials supporting US FDA approval of Vuity (2021), MHRA prescribing guidance, the Royal College of Ophthalmologists, and emerging UK private prescribing experience. Evidence for surgical interventions draws on peer-reviewed comparative literature on PRESBYOND blended vision (Zeiss), Vivity and Symfony EDOF IOLs, Tecnis Eyhance enhanced monofocal, PanOptix Pro, AT LISA tri and FineVision trifocal IOLs, the RxSight Light Adjustable Lens, and the IC-8 Apthera small-aperture IOL, plus ESCRS and AAO clinical guidance. Page last reviewed 23 May 2026 against the live URL set on eyesurgeryclinic.co.uk.

Map your presbyopia options — drops or surgery

Book a same-week consultant refractive assessment with full biometry, corneal imaging and an ocular surface check, then receive a fully transparent UK 2026 quote across drops, PRESBYOND, RLE, EDOF, trifocal, Light Adjustable Lens and IC-8 Apthera.

Book a free online consultation Make an appointment

Or call 0800 852 7782.

Back to Prices

Updated on 22 May 2026